Ross Clark

Europe

What the Lancet study tells us about the Oxford vaccine

All the participants who received the half dose followed by a full dose were under 55

By Ross Clark

Europe

What we don’t yet know about the Oxford vaccine

If one vaccine provides immunity lasting months and another years, the relative costs of each could shift dramatically

By Ross Clark

Europe

Do some people have hidden immunity against COVID?

Over 50 million cases of COVID-19 have now been recorded globally — and yet only a handful of cases of reinfection have been documented

By Ross Clark

China

What if the virus that causes COVID was man-made?

A new paper looks at the possibility that SARS-CoV-2 was artificially created

By Ross Clark

The Moderna vaccine offers more hope

The company can provisionally claim that their vaccine is 94.5 percent effective

By Ross Clark

COVID-19 is distracting us from another medical emergency

The estimated number of deaths globally from measles climbed to 207,500 in 2019

By Ross Clark

Will the Pfizer vaccine live up to the hype?

Any vaccine that proves partly effective will be welcomed with open arms by a world which largely remains in lockdown or semi-lockdown

By Ross Clark

Europe

Should we be worried by declining COVID antibodies?

If antibodies were our only defense, surely we would be seeing vast numbers of reinfections?

By Ross Clark

Europe

The US is coming out of COVID no worse than any European country

No one is telling Americans to ‘look at the EU’ anymore

By Ross Clark

How deadly is COVID-19?

A Stanford professor has produced perhaps the most comprehensive attempt to estimate the infection fatality rate

By Ross Clark

The curious case of the man who caught COVID twice

A team at the University of Nevada has been studying him

By Ross Clark

Europe

Could we see COVID anti-virals before a vaccine?

It was therapeutic drugs that in the end made HIV less deadly

By Ross Clark

The growing case for T cell COVID immunity

Several studies bring into question a central assumption of the global response to COVID-19

By Ross Clark

Europe

Europe’s ‘second wave’ has fizzled out

New cases are now declining in Germany, and Sweden, and remaining flat in Italy, Ireland and Belgium

By Ross Clark

We may be closer to herd immunity than previously thought

Are we fearing a ‘second wave’ which our immune systems already have well in hand?

By Ross Clark

more writers

Stay informed

Thought-provoking commentary and opinion on politics, books and the arts.

Web-only content Copyright © 2021 The Spectator // Magazine content Copyright © 2021 The Spectator